Crinetics Pharmaceuticals, Inc. ($CRNX): Caution Is Advised (2019-07-29)

Investing in Crinetics Pharmaceuticals, Inc.? If so, we recommend checking out these offers as well (we believe these to be much more interesting):

Cannabis Trader:
Trade Netflix:
Wall Street Journal: (only $12 for 12 weeks – everyone should get this)

REPORTING FOR 2019-07-29 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how Crinetics Pharmaceuticals, Inc. ($CRNX) has been trading over the last 2 weeks and the past day especially. On its latest session, Crinetics Pharmaceuticals, Inc. ($CRNX) opened at 22.4, reaching a high of 22.99 and a low of 21.72 before closing at a price of 22.03. There was a total volume of 59772.

VOLUME INDICATORS: We saw an accumulation-distribution index of 146.07257, an on-balance volume of 22.33, chaikin money flow of 3.30508 and a force index of 2.6676. There was an ease of movement rating of 0.01446, a volume-price trend of -1.95134 and a negative volume index of 1000.0.

VOLATILITY: We noted an average true range of 0.70779, bolinger bands of 22.84939, an upper bollinger band of 21.18061, lower bollinger band of 21.72, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 22.37, high band keltner channel of 21.78, low band keltner channel of 22.96, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 21.72, a donchian channel low band of 21.72, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.

TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.01324, a MACD signal of 0.00735, a MACD difference of 0.00588, a fast Exponential Moving Average (EMA) indicator of 21.72, a slow Exponential Moving Average (EMA) indicator of 21.72, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.13139, a trix of -8.32688, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of 2.1391, a KST Oscillator (KST) of -89.65537 and a KST Oscillator (KST Signal) of -89.65537 (leaving a KST difference of 6.18213). We also found an Ichimoku rating of 22.695, an Ichimoku B rating of 22.695, a Ichimoku visual trend A of 24.67091, an Ichimoku visual trend B of 24.6008, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.

MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 51.6933, a True Strength Index (TSI) of -100.0, an ultimate oscillator of -146.12885, a stochastic oscillator of 215.25424, a stochastic oscillator signal of 215.25424, a Williams %R rating of 115.25424 and an awesome oscillator of 0.21658.

RETURNS: There was a daily return of -8.96554, a daily log return of 2.68015 and a cumulative return of 2.71639.

What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-29 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Crinetics Pharmaceuticals, Inc. ($CRNX)…

For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Crinetics Pharmaceuticals, Inc., we strongly advise Crinetics Pharmaceuticals, Inc. investors to subscribe to’s daily email newsletter for updates, news and analyst ratings on stocks like Crinetics Pharmaceuticals, Inc. – without this you are trading blind:

We will of course continue to cover the news and price action of Crinetics Pharmaceuticals, Inc., but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.

DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Crinetics Pharmaceuticals, Inc. ($CRNX) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.

Gary Ivenchuck

Gary is a stock trading expert and is responsible for covering technical analysis news on Logistics Business Review. Recently he has been working tirelessly to analyse stocks for our readers, and is always available to hear from people asking for stock analysis.
Gary Ivenchuck

Leave a Reply

Your email address will not be published. Required fields are marked *